Wilson v. Centene Management Company, LLC

CourtDistrict Court, W.D. Texas
DecidedAugust 4, 2023
Docket1:20-cv-00484
StatusUnknown

This text of Wilson v. Centene Management Company, LLC (Wilson v. Centene Management Company, LLC) is published on Counsel Stack Legal Research, covering District Court, W.D. Texas primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Wilson v. Centene Management Company, LLC, (W.D. Tex. 2023).

Opinion

UNITED STATES DISTRICT COURT WESTERN DISTRICT OF TEXAS AUSTIN DIVISION

ERIN ANGELO, NICHOLAS § ANGELO, AND CYNTHIA § WILSON, on behalf of themselves § and all others similarly situated, § Plaintiffs § § v. § No. 1:20-cv-00484-RP § CENTENE MANAGEMENT § COMPANY, LLC, CELTIC § INSURANCE COMPANY, § SUPERIOR HEALTH PLAN, INC., § and CENTENE COMPANY OF § TEXAS, L.P., § Defendants

REPORT AND RECOMMENDATION AND ORDER OF THE UNITED STATES MAGISTRATE JUDGE

TO: THE HONORABLE ROBERT PITMAN UNITED STATES DISTRICT JUDGE

Before the Court is Plaintiffs’ Motion for Class Certification, Dkt. 62; Defendants’ Motion to Exclude Expert Testimony, Dkt. 70; and all related briefing. After reviewing these filings, and the relevant case law, the undersigned denies Defendants’ Motion to Exclude Expert Testimony and recommends that the District Court deny Plaintiffs’ Motion for Class Certification. I. BACKGROUND This is a class action on behalf of all individuals in the State of Texas who from January 1, 2014, through December 31, 2021 (the “Class Period”) were insured for health care under the Ambetter insurance policy sold and managed by Defendants. Dkts. 62 at 1; 1, at 14. Plaintiffs allege that the lists of providers represented to be available to insureds were materially inaccurate in that they contained thousands of names of providers who were not available to provide medical care. Dkts. 62, at 1; 1,

at 13. As a result, the premiums paid by class members were artificially inflated because policyholders were charged for access to providers who were not in fact available to them. Dkts. 62, at 1; 1, at 5, 14. This class action seeks to recover the alleged overcharges. Dkts. 62, at 1; 1, at 5, 14, 26. The health insurance policies at issue are offered under the Affordable Care Act and sold through the government’s Affordable Care Act marketplace at healthcare.gov. Dkt. 63, at 7. The healthcare.gov listings for available policies list

price, co-pay amounts, deductibles, and offer the ability to search the provider database—but the listings do not include the number of providers in the network. Id. However, Defendants are required to maintain “a network that is sufficient in number and types of providers [to] ensure that all services will be accessible without unreasonable delay.” 45 C.F.R. §§ 156.230(a)(2), 156.230(a)(1)(ii). Plaintiffs filed the pending motion for class certification seeking to certify a

class of “all persons in the State of Texas who were insured by Defendants’ Ambetter insurance product which was purchased through the [Affordable Care Act] HIE from the date on which the Ambetter policies were first sold in Texas to December 31, 2021,” a class of more than 400,000 people. Dkts. 62, at 7; 1, at 26. Plaintiffs seek compensation for alleged overpayment of insurance premiums due to inflated insurance premium prices. Dkt. 62, at 1. The gravamen of Plaintiffs’ complaint is the theory that the defendant insurance companies misrepresented the accuracy, size, and availability of providers of their network since it was “not as robust as Defendants represent it to be” and therefore caused Plaintiffs to pay inflated

insurance premiums. Dkt. 74, at 2. Plaintiffs ask the Court to conditionally certify this suit as a collective action. Dkt. 62, at 1. Defendants responded and separately moved to strike the declarations included in the Plaintiffs’ motion for class certification on the grounds that the Plaintiffs do not have Article III standing, and do not fulfill the Rule 23(b)(3) requirements of predominance and superiority. Dkt. 63, at 1. Further, Defendants also moved to exclude one of Plaintiffs’ Class Certification Motion Experts on the

grounds that the expert's methodology for measuring damages is unreliable, and thus that it does not pass the Daubert standard. Dkt. 70, at 1. II. DEFENDANTS’ MOTION TO STRIKE Before turning to the class certification motion, the undersigned addresses Defendants’ motion to strike Plaintiffs’ expert testimony in support of class certification. Defendants object to the testimony of Plaintiffs’ expert, Dr. Simon. F.

Haeder, arguing that his testimony is unreliable and irrelevant, and therefore does not pass the standard set in Daubert. Dkt. 70, at 9. Defendants posit five reasons why Dr. Haeder’s testimony should be excluded: (1) Dr. Haeder’s damages model improperly assumes that Superior made a promise that is not contained in the relevant contract; (2) Dr. Haeder’s model does not measure the harm that flows from an inaccurate directory; (3) Dr. Haeder’s model is inconsistent with the governing law; (4) Dr. Haeder relies on improper assumptions about Superior’s network breadth; and (5) Dr. Haeder’s model fails to account for supply-side factors. Dkt. 76, at 2-9.

A. Legal Standard Federal Rule of Evidence 702 sets the standard for the admissibility of expert testimony. The gatekeeping function identified in Daubert v. Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579 (1993), “imposes a special obligation upon a trial judge to ‘ensure that any and all scientific testimony ... is not only relevant, but reliable.’” Kumho Tire Co., Ltd. v. Carmichael, 526 U.S. 137, 147 (1999) (quoting Daubert, 509 U.S. at 589). Rule 702 provides that:

A witness who is qualified as an expert ... may testify ... in the form of an opinion ... if (a) the expert’s scientific, technical, or other specialized knowledge will help the trier of fact to understand the evidence or to determine a fact in issue; (b) the testimony is based on sufficient facts or data; (c) the testimony is the product of reliable principles and methods; and (d) the expert has reliably applied the principles and methods to the facts of the case. Fed. R. Evid. 702. Under Daubert, expert testimony is admissible if the proponent demonstrates that (1) the expert is qualified; (2) the evidence is relevant; and (3) the evidence is reliable. See Moore v. Ashland Chem. Inc., 151 F.3d 269, 276 (5th Cir. 1998); Watkins v. Telsmith, Inc., 121 F.3d 984, 989 (5th Cir. 1997). “The inquiry envisioned by Rule 702 is, we emphasize, a flexible one. Its overarching subject is the scientific validity and thus the evidentiary relevance and reliability—of the principles that underlie a proposed submission. The focus, of course, must be solely on principles and methodology, not on the conclusions that they generate.” Watkins, 121 F.3d at 989.

“As a general rule, questions relating to the bases and sources of an expert’s opinion affect the weight to be assigned that opinion rather than its admissibility and should be left for the jury’s consideration.” Viterbo v. Dow Chem. Co., 826 F.2d 420, 422 (5th Cir. 1987). “To trigger a Daubert inquiry, an expert’s testimony, or its ‘factual basis, data, principles, methods, or their application,’ must be ‘called sufficiently into question.’” Rodriguez v. Riddell Sports, Inc., 242 F.3d 567, 581 (5th Cir. 2001) (quoting Kumho, 526 U.S. at 149).

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Watkins v. Telsmith, Inc.
121 F.3d 984 (Fifth Circuit, 1997)
Moore v. Ashland Chemical Inc.
151 F.3d 269 (Fifth Circuit, 1998)
Eleven Line, Inc. v. North Texas State Soccer Ass'n
213 F.3d 198 (Fifth Circuit, 2000)
Rodriguez v. Riddell Sports, Inc.
242 F.3d 567 (Fifth Circuit, 2001)
Coghlan v. Wellcraft Marine Corp.
240 F.3d 449 (Fifth Circuit, 2001)
Warth v. Seldin
422 U.S. 490 (Supreme Court, 1975)
Thomas v. Arn
474 U.S. 140 (Supreme Court, 1986)
Daubert v. Merrell Dow Pharmaceuticals, Inc.
509 U.S. 579 (Supreme Court, 1993)
Kumho Tire Co. v. Carmichael
526 U.S. 137 (Supreme Court, 1999)
Bobby Battle v. U.S. Parole Commission
834 F.2d 419 (Fifth Circuit, 1987)
Comcast Corp. v. Behrend
133 S. Ct. 1426 (Supreme Court, 2013)
Carlson v. Bioremedi Therapeutic Systems, Inc.
822 F.3d 194 (Fifth Circuit, 2016)
Thomas Martone v. Walter Robb, III
902 F.3d 519 (Fifth Circuit, 2018)
Nina Flecha v. Medicredit, Incorporated
946 F.3d 762 (Fifth Circuit, 2020)
TransUnion LLC v. Ramirez
594 U.S. 413 (Supreme Court, 2021)
Earl v. Boeing
53 F.4th 897 (Fifth Circuit, 2022)

Cite This Page — Counsel Stack

Bluebook (online)
Wilson v. Centene Management Company, LLC, Counsel Stack Legal Research, https://law.counselstack.com/opinion/wilson-v-centene-management-company-llc-txwd-2023.